Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP792015.RAZKg6GH-TULlQNd1G8Y013Rrq9j0w6o78p7OjCZ8h65I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP792015.RAZKg6GH-TULlQNd1G8Y013Rrq9j0w6o78p7OjCZ8h65I130_assertion type Assertion NP792015.RAZKg6GH-TULlQNd1G8Y013Rrq9j0w6o78p7OjCZ8h65I130_head.
- NP792015.RAZKg6GH-TULlQNd1G8Y013Rrq9j0w6o78p7OjCZ8h65I130_assertion description "[The therapeutic efficacy of AxdAdB-3 for the treatment of prostate cancer was investigated in an orthotopic prostate cancer model established with DU145 in severe combined immunodeficiency (SCID) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP792015.RAZKg6GH-TULlQNd1G8Y013Rrq9j0w6o78p7OjCZ8h65I130_provenance.
- NP792015.RAZKg6GH-TULlQNd1G8Y013Rrq9j0w6o78p7OjCZ8h65I130_assertion evidence source_evidence_literature NP792015.RAZKg6GH-TULlQNd1G8Y013Rrq9j0w6o78p7OjCZ8h65I130_provenance.
- NP792015.RAZKg6GH-TULlQNd1G8Y013Rrq9j0w6o78p7OjCZ8h65I130_assertion SIO_000772 18158069 NP792015.RAZKg6GH-TULlQNd1G8Y013Rrq9j0w6o78p7OjCZ8h65I130_provenance.
- NP792015.RAZKg6GH-TULlQNd1G8Y013Rrq9j0w6o78p7OjCZ8h65I130_assertion wasDerivedFrom befree-20140225 NP792015.RAZKg6GH-TULlQNd1G8Y013Rrq9j0w6o78p7OjCZ8h65I130_provenance.
- NP792015.RAZKg6GH-TULlQNd1G8Y013Rrq9j0w6o78p7OjCZ8h65I130_assertion wasGeneratedBy ECO_0000203 NP792015.RAZKg6GH-TULlQNd1G8Y013Rrq9j0w6o78p7OjCZ8h65I130_provenance.